Free Newsletter
Roche still confident on Ventana buyout
Does he know something we don't? Roche CEO Franz Humer says he's "very confident" that the company's $3 billion takeover bid for Ventana will be accepted.
Humer also told the Financial Times today that hedge funds have bought out Ventana's leading shareholders. And he has "no intention" of increasing the value of Roche's tender offer, despite the fact that the $75 buyout price is less than Ventana's current stock price.
- read the Financial Times article
Related Articles:
Roche asks, Ventana says no...again. Report
Roche wins round in battle for Ventana. Report
Roche note opens door to a higher Ventana bid. Report
Ventana spurns Roche's $3B hostile takeover bid. Report
Ventana shares soar on hostile $3B bid. Report
Read more on: Roche
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: